# Octapharma AB – FDA Inspection, Sep 28, 2018

Source: https://www.keypedia.com/records/fda_inspections/octapharma-ab/d1bd9bce-fbba-4979-be9f-74a49e7eed87
Source feed: FDA_Inspections

> FDA inspection 1070173 of Octapharma AB, September 28, 2018. Classification: Voluntary Action Indicated (VAI). Form 483 issued. 6 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1070173
- Company Name: Octapharma AB
- Inspection Date: 2018-09-28
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Center: Biologics
- Office Name: Center for Biologics Evaluation and Research
- Citation Count: 0

## Related Documents

- [FDA Inspection 1218250 - 2023-09-19](https://www.keypedia.com/records/fda_inspections/octapharma-ab/3645f477-d675-40fc-90b8-3704a595408d)
- [FDA Inspection 994537 - 2016-10-03](https://www.keypedia.com/records/fda_inspections/octapharma-ab/6b3e378f-099f-4e8b-a570-ba2acbf16cb8)
- FDA Inspection 894095 - 2014-04-28
- FDA Inspection 783783 - 2012-01-19
- [FDA Inspection 710676 - 2011-01-20](https://www.keypedia.com/records/fda_inspections/octapharma-ab/e46fa3b2-794a-456e-97d5-2b973b8e1194)

## Related Officers

- [Eileen A. Liu](https://www.keypedia.com/people/eileen-a-liu/fa051db4-1242-4181-9af9-5b3cd2de5689)
- [Investigator](https://www.keypedia.com/people/jennifer-l-reed/56fd0817-0bda-4148-8d3a-61093961390d)
- [FDA Associated Person](https://www.keypedia.com/people/prabhu-p-raju/2c0aaede-fe16-4431-bc21-614d7f18cb32)

Company: https://www.keypedia.com/companies/octapharma-ab/5a456872-4ca6-4418-b006-6e7e219ec262

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d